Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV/AIDS and blindness.

P G Kestelyn1, E T Cunningham

  • 1Department of Ophthalmology, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. philippe.kestelyn@rug.ac.be

Bulletin of the World Health Organization
|April 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitiligo iridis in patients with a history of smallpox infection.

Eye (London, England)·2010
Same author

Spontaneous hyphaema and acute ocular hypertension associated with severe lens-induced uveitis.

Eye (London, England)·2010
Same author

Unexplained vision loss following removal of epiretinal membrane.

The British journal of ophthalmology·2010
Same author

Conjunctival lymphoma following treatment with cyclophosphamide.

Eye (London, England)·2010
Same author

Delayed fellow eye involvement in patients with Vogt-Koyanagi-Harada disease.

The British journal of ophthalmology·2009
Same author

Atypical presentation of syphilitic uveitis associated with Kyrieleis plaques.

The British journal of ophthalmology·2008
Same journal

Diplomatic roles of regional coordinators for WHO Member States.

Bulletin of the World Health Organization·2026
Same journal

Evaluation of an application for investments in cataract surgery, Ethiopia.

Bulletin of the World Health Organization·2026
Same journal

An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

Bulletin of the World Health Organization·2026
Same journal

Fundamental changes in regulation to improve access to biosimilars.

Bulletin of the World Health Organization·2026
Same journal

A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

Bulletin of the World Health Organization·2026
Same journal

Ebola at a critical juncture: preparedness must outpace transmission.

Bulletin of the World Health Organization·2026
See all related articles

Ocular complications are common in people with HIV/AIDS, with Cytomegalovirus retinitis being a leading cause of vision loss. While treatments are improving, HIV-related eye conditions remain a significant global health concern.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Public Health

Background:

  • Ocular complications affect 50-75% of individuals with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS).
  • Cytomegalovirus (CMV) retinitis is the most frequent cause of vision loss in patients with AIDS.
  • While decreasing in industrialized nations due to antiretroviral therapy, CMV retinitis still impacts 10-20% globally.

Purpose of the Study:

  • To summarize the spectrum of ocular complications in patients with HIV/AIDS.
  • To highlight the impact of Cytomegalovirus retinitis on vision loss.
  • To discuss the changing landscape of HIV-related eye diseases with the advent of antiretroviral therapy.

Main Methods:

  • Review of existing literature on HIV/AIDS and ocular manifestations.

Related Experiment Videos

  • Analysis of prevalence data for various ocular conditions in HIV-infected individuals.
  • Discussion of etiological factors and treatment implications.

    • Main Results:

    • Cytomegalovirus retinitis is the primary cause of vision loss in HIV/AIDS patients.
    • Other significant causes include varicella zoster virus, herpes simplex virus retinitis, HIV microvasculopathy, syphilis, tuberculosis, cryptococcal meningitis, and drug reactions.
    • Vision loss in developing countries is often associated with limited life expectancy, but this may change with increased access to antiretroviral therapy.

    Conclusions:

    • HIV/AIDS patients face a high risk of vision loss due to various ocular complications, notably CMV retinitis.
    • The global prevalence and impact of these conditions are influenced by access to effective antiretroviral therapy.
    • Increased life expectancy due to treatment may lead to a rise in the prevalence of blindness related to HIV/AIDS in developing regions.